Financial Data and Key Metrics Changes - The company reported full-year revenue growth of 6% to $6.3 billion, achieving its highest-ever revenue, EBITDA, and operating cash flow in 2025 [7][19] - Fourth quarter revenue was $1.61 billion, essentially flat year-over-year, with adjusted EBITDA of $134 million, which was 2% above the implied guidance midpoint [18][19] - Operating cash flow for 2025 was $471 million, up nearly 50% from the previous year, with a significant increase in cash reserves to over $710 million [6][21] Business Line Data and Key Metrics Changes - Admissions and adjusted admissions grew by 5.3% and 2.3% respectively for the full year 2025, with fourth quarter admissions increasing by 1.5% and adjusted admissions growing by 2% [7][18] - The company achieved a 9% growth in adjusted EBITDA for the full year, with margins expanding by 20 basis points to 8.6% [19] Market Data and Key Metrics Changes - The company’s markets are growing two to three times faster than the national average, supported by rising care complexity [14] - Payer denials in Q4 remained consistent with Q3, showing early signs of improvement, while professional fees growth decelerated to 8% from 11% in Q3 [12] Company Strategy and Development Direction - The company is focused on optimizing revenue, disciplined expense management, and productivity while delivering quality care [14] - The IMPACT program is a multi-year initiative aimed at improving margins, performance, and care transformation, with expected savings raised to approximately $55 million for 2026 [9][24] - The deployment of AI and technology is a key part of the company’s transformation strategy, enhancing operational efficiency and care delivery [15][16] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company’s performance and momentum heading into 2026, despite industry headwinds [6][14] - The company expects adjusted EBITDA guidance for 2026 to be between $485 million and $535 million, reflecting core earnings growth and IMPACT program savings [14][22] Other Important Information - The company strengthened its balance sheet during 2025, reducing lease-adjusted net leverage to 2.5x and total net leverage to 0.8x [21] - The company repurchased $3 million of stock during the fourth quarter, with $47 million remaining under its repurchase authorization [21] Q&A Session Summary Question: Professional fees increase in 2025 and expectations for 2026 - Professional fee growth in 2025 was in the high single-digit range, with similar assumptions for 2026 [31][32] Question: Expected volume declines in 2026 - The company is planning for a 20% decline in enrollment, with 10%-15% moving to employer-sponsored coverage and the rest going to self-pay [36][37] Question: Details on the $15 million increase in the IMPACT program - The majority of the $15 million increment identified is in the salaries, wages, and benefits line [38] Question: IMPACT initiatives with longer lead times - The IMPACT initiatives are designed to be multiyear and sustainable, with ongoing opportunities in supply chain and revenue cycle management [42] Question: Volume impact from winter storms - The primary impacts were in Texas and Oklahoma, with minimal expected impact on Q1 overall [45] Question: Cash flow growth in line with EBITDA - A $50 million headwind from payroll timing is expected, but cash flows are anticipated to follow consistent with the 2026 guidance [67] Question: Update on ambulatory or outpatient strategy - The company is expanding its urgent care and outpatient services, with several new facilities planned [65] Question: Length of stay and payer class variations - Length of stay is influenced by acuity and efficiency, with ongoing efforts to improve performance [91] Question: Impact of CMS waiver model and AI tools on denial rates - The company is not assuming significant changes in denial trends but is optimistic about technological advances aiding performance [93]

Ardent Health (NYSE:ARDT) Q4 2025 Earnings call March 05, 2026 10:00 AM ET Speaker8Good morning, and thank you for standing by. My name is John, and I will be your conference operator today. At this time, I would like to welcome everyone to the Ardent Health Fourth Quarter and Full Year 2025 Earnings Call. All lines have been placed in mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during this time, simply p ...